News and reflections from the world of AI

Aiforia receives a contract award to provide AI solutions for 25 NHS hospitals of the PathLAKE Plus consortium in the UK

Aiforia has received a contract award to provide artificial intelligence solutions for 25 NHS Trusts pathology departments in the UK to support the diagnosis of patients. The Contract Award enables the Trusts to purchase directly from Aiforia and to sign individual contracts without worksome tender processes. The technology of the awarded vendor has already been qualified for clinical use, and ...

End of 2022 year message from the CEO

Hi everyone, Looking back on what we have achieved this year, first and foremost, I am incredibly proud of our team.

Introducing Aiforia Education

Aiforia is excited to present the newly rebranded Aiforia Education, formerly known as Aiforia Hub for Education. What is Aiforia Education? Aiforia Education is a cloud-based software for e-learning that allows teachers to unbind themselves and their students from microscopes, classrooms, and printed materials. The platform enables educators to upload sample images from any microscope scanner ...

Aurora mScope partners with Aiforia to Bring Integrated AI and Image Management Systems to Pathologists

With this integration, pathology departments can utilize Aiforia’s clinical grade, CE-IVD marked AI models or ones built using Aiforia Create, and automatically import the results into Aurora mScope Clinical, with its rich image management, case management, workflow, and reporting feature set.

Aiforia makes key advancement towards end-to-end clinical pathology workflow solution with the release of its CE-IVD marked Aiforia® Clinical Suite Viewer

Aiforia Technologies Plc is thrilled to announce it received CE-IVD marking for the Aiforia® Clinical Suite Viewer, a cloud-based platform enabling a holistic approach to cancer diagnostics and prognostics through the viewing of whole slide digital images of human histopathological samples and deep learning AI produced results along with their seamless reporting. The Aiforia viewer provides ...

Aiforia releases another CE-IVD marked clinical AI Model — expanding its diagnostic pathology offering to prostate cancer

This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5 CE-IVD marked clinical AI models for breast, lung, and now prostate cancer — the most commonly occurring cancer in men. According to the World Cancer Research Fund, more than 1.4 million new cases of prostate cancer were diagnosed in 2020. Both pathologists and patients deserve reliable ...